Literature DB >> 12576554

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

Kazuhiro Ohmi1, David S Greenberg, Kavitha S Rajavel, Sergey Ryazantsev, Hong Hua Li, Elizabeth F Neufeld.   

Abstract

Alpha-N-acetylglucosaminidase deficiency (mucopolysaccharidosis IIIB, MPS IIIB) and alpha-l-iduronidase deficiency (MPS I) are heritable lysosomal storage diseases; neurodegeneration is prominent in MPS IIIB and in severe cases of MPS I. We have obtained morphologic and molecular evidence for the involvement of microglia in brain pathology of mouse models of the two diseases. In the cortex, a subset of microglia (sometimes perineuronal) consists of cells that are probably phagocytic; they have large storage vacuoles, react with MOMA-2 (monoclonal antibody against macrophages) and Griffonia simplicifolia isolectin IB(4), and stain intensely for the lysosomal proteins Lamp-1, Lamp-2, and cathepsin D as well as for G(M3) ganglioside. MOMA-2-positive cells appear at 1 and 6 months in MPS IIIB and MPS I mice, respectively, but though their number increases with age, they remain sparse. However, a profusion of cells carrying the macrophage CD68/macrosialin antigen appear in the cortex of both mouse models at 1 month. mRNA encoding CD68/macrosialin also increases at that time, as shown by microarray and Northern blot analyses. Ten other transcripts elevated in both mouse models are associated with macrophage functions, including complement C4, the three subunits of complement C1q, lysozyme M, cathepsins S and Z, cytochrome b558 small subunit, macrophage-specific protein 1, and DAP12. An increase in IFN-gamma and IFN-gamma receptor was observed by immunohistochemistry. These functional increases may represent activation of resident microglia, an influx and activation of blood monocytes, or both. They show an inflammatory component of brain disease in the two MPS, as is known for many neurodegenerative disorders.

Entities:  

Mesh:

Year:  2003        PMID: 12576554      PMCID: PMC149931          DOI: 10.1073/pnas.252784899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Expression of rat cathepsin S in phagocytic cells.

Authors:  S Petanceska; P Canoll; L A Devi
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

Review 2.  Microglia as mediators of inflammatory and degenerative diseases.

Authors:  F González-Scarano; G Baltuch
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

3.  Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.

Authors:  B Hess; P Saftig; D Hartmann; R Coenen; R Lüllmann-Rauch; H H Goebel; M Evers; K von Figura; R D'Hooge; G Nagels; P De Deyn; C Peters; V Gieselmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Isolation of a novel macrophage-specific gene by differential cDNA analysis.

Authors:  K Spilsbury; M A O'Mara; W M Wu; P B Rowe; G Symonds; Y Takayama
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

5.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.

Authors:  L L Lanier; B C Corliss; J Wu; C Leong; J H Phillips
Journal:  Nature       Date:  1998-02-12       Impact factor: 49.962

6.  A role for preadipocytes as macrophage-like cells.

Authors:  B Cousin; O Munoz; M Andre; A M Fontanilles; C Dani; J L Cousin; P Laharrague; L Casteilla; L Pénicaud
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

7.  Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.

Authors:  L A Clarke; C S Russell; S Pownall; C L Warrington; A Borowski; J E Dimmick; J Toone; F R Jirik
Journal:  Hum Mol Genet       Date:  1997-04       Impact factor: 6.150

8.  Interferon gamma gene expression in rat central nervous system glial cells.

Authors:  R De Simone; G Levi; F Aloisi
Journal:  Cytokine       Date:  1998-06       Impact factor: 3.861

9.  Murine MPS I: insights into the pathogenesis of Hurler syndrome.

Authors:  C Russell; G Hendson; G Jevon; T Matlock; J Yu; M Aklujkar; K Y Ng; L A Clarke
Journal:  Clin Genet       Date:  1998-05       Impact factor: 4.438

10.  Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation.

Authors:  M Munder; M Mallo; K Eichmann; M Modolell
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  177 in total

1.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

Review 2.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

3.  Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I).

Authors:  Louise D Archer; Kia J Langford-Smith; William R Critchley; Brian W Bigger; James E Fildes
Journal:  J Inherit Metab Dis       Date:  2012-07-07       Impact factor: 4.982

4.  Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.

Authors:  Coy D Heldermon; Kevin K Ohlemiller; Erik D Herzog; Carole Vogler; Elizabeth Qin; David F Wozniak; Yun Tan; John L Orrock; Mark S Sands
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

5.  Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).

Authors:  Daniela G Seidler; Muhammad Faiyaz-Ul-Haque; Uwe Hansen; George W Yip; Syed H E Zaidi; Ahmad S Teebi; Ludwig Kiesel; Martin Götte
Journal:  J Mol Med (Berl)       Date:  2006-04-01       Impact factor: 4.599

6.  CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome).

Authors:  Sandra Motas; Virginia Haurigot; Miguel Garcia; Sara Marcó; Albert Ribera; Carles Roca; Xavier Sánchez; Víctor Sánchez; Maria Molas; Joan Bertolin; Luca Maggioni; Xavier León; Jesús Ruberte; Fatima Bosch
Journal:  JCI Insight       Date:  2016-06-16

7.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

Review 8.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

9.  Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death.

Authors:  Ik-Hyun Cho; Jinpyo Hong; Eun Cheng Suh; Jae Hwan Kim; Hyunkyoung Lee; Jong Eun Lee; Soojin Lee; Chong-Hyun Kim; Dong Woon Kim; Eun-Kyeong Jo; Kyung Eun Lee; Michael Karin; Sung Joong Lee
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

10.  Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome.

Authors:  Daren Wang; Wei Zhang; Theodosia A Kalfa; Gregory Grabowski; Stella Davies; Punam Malik; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.